Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response.
Here, we sought to determine whether peptide vaccines designed harbor both class I as well as class II restricted antigenic motifs could concurrently induce CD4 and CD8 T cell activation against autologous tumor antigens. Based on our prior genome-wide interrogation of human prostate cancer tissues...
Saved in:
| Main Authors: | Haydn T Kissick, Martin G Sanda, Laura K Dunn, Mohamed S Arredouani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0093231&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of conserved peptide-MHC epitopes for directly alloreactive CD8+ T cells
by: Alexandra E. Hill, et al.
Published: (2025-01-01) -
Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.
by: Alexandra J Spencer, et al.
Published: (2014-01-01) -
Revealing novel and conservative CD8+T-cell epitopes with MHC B2 restriction on ALV-J
by: Xueqing Li, et al.
Published: (2024-12-01) -
Prognostic nutrition index reveals LAG3 in cytotoxic CD8+ T cells and MHC class II in gastric cancer cells
by: Chikanori Tsutsumi, et al.
Published: (2025-04-01) -
A Multiple Antigen Peptide Vaccine Containing CD4+ T Cell Epitopes Enhances Humoral Immunity against Trichinella spiralis Infection in Mice
by: Yuan Gu, et al.
Published: (2020-01-01)